In the last decade more than half a hundred articles on the therapeutic value of amphetamine sulfate (benzedrine) have appeared in the medical literature. Within the last few months its analogue dextroamphetamine sulfate (dexedrine), which qualitatively is similar, has been introduced to the medical profession. It presumably has all the advantages of amphetamine sulfate but causes fewer undesirable vascular reactions.1
In spite of its increasing widespread use in medical practice, and although numerous toxic reactions have been reported,2 a thorough review of the literature of the last ten years reveals but 1 questionable instance of dermatitis.3
The well known untoward cutaneous reactions of amphetamine sulfate have been reviewed by Reifenstein and Davidoff,2 who list flushing of the face, urticaria, cutis anserina, characteristic bromidrosis, dermatographia, pustular eruption, cyanosis, xeroderma, coldness and clamminess of the hands, paresthesia and similar effects.
Goldsmith3 presented a questionable eruption on the
Kauvar SS, Henschel EJ, Ravin A. TOXIC ERUPTION DUE TO AMPHETAMINE SULFATE AND ITS ANALOGUE DEXTROAMPHETAMINE SULFATE. JAMA. 1943;122(16):1073–1074. doi:10.1001/jama.1943.72840330004005b
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: